United States Pain Management Therapeutics Market, Patients Volume, and 50 Company’s Pipeline Analysis (By Product, Indication, Phase of Development)

Publisher Name :
Date: 09-Aug-2017
No. of pages: 77

The United States market for pain management therapeutics remains a substantial growth area for pharmaceutical companies, as they continue their efforts to maintain significant growth margins by tapping into markets of major unmet medical needs. United States Pain Therapeutics market persists with regular developments and discoveries of new drugs addressing pain related health ailment issue. The widespread availability of drugs and the advent of new drugs have accelerated the pace of growth in the market.

The pain management market is fueled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post-operative pain relief markets. The largest segment of the United States pain management market is the arthritis while pediatric pain is the smallest segment for the pain management. The cancer pain management market is the most rapidly growing segment of the United States pain management market.

“United States Pain Management Therapeutics Market, Patients Volume, and 50 Company’s Pipeline Analysis (By Product, Indication, Phase of Development)” provides a comprehensive assessment of the fast-evolving, high-growth of United States Pain Management Therapeutics Sector.

This 77 Page report with 45 Figures and 3 Tables studies in details:


  • United States Pain Management Therapeutics Market and Forecast (2007 - 2022)

  • United States Pain Management Patients Volume and Forecast (2007 - 2022)

  • 50 Company’s Pipeline Product Analysis (By Product, Indication, Phase of Development)

  • United States Pain Management Therapeutics Market - Driving Factors & Challenges


10 Pain Management Segments covered in the report are as follows


  • Arthritis Pain

  • Migraine Pain

  • Post-Operative Pain

  • Cancer Pain

  • Neuropathic Pain

  • Back Pain

  • Fibromyalgia Pain

  • Facial Pain

  • Pediatric Pain

  • Obstetrical Pain


Company Wise Pipeline Analysis (By Product, Indication, Phase of Development) – 50 Companies Covered


  • Teva Pharmaceutical

  • Astellas Pharmaceuticals Inc.

  • Durect Corporation

  • Pfizer

  • AbbVie Inc.

  • AcelRx Pharmaceuticals, Inc.

  • Acorda Therapeutics Inc.

  • Achelios Therapeutics

  • Alder BioPharmaceuticals Inc.

  • Allergan

  • Amgen Inc.

  • AstraZeneca/MedImmune

  • Avanir Pharmaceuticals Inc.

  • Axsome Therapeutics, Inc

  • BioDelivery Sciences International

  • Cara Therapeutics

  • COLLEGIUM Pharmaceutical Inc.

  • Centrexion Therapeutics

  • Daiichi Sankyo Company Ltd.

  • Depomed Inc.

  • Egalet Corporation

  • Eli Lilly and Company

  • Endo Pharmaceuticals Inc.

  • EpiCept

  • FemmePharma

  • Flexion Therapeutics Inc.

  • Galapagos NV

  • Heron Therapeutics

  • Helsinn Healthcare SA

  • INSYS THERAPEUTICS, INC

  • Iroko Pharmaceuticals

  • KemPharm, Inc

  • Mesoblast Ltd

  • Novartis International AG

  • Nuvo Pharmaceuticals

  • Nektar Therapeutics

  • NeurAxon

  • Newron Pharmaceuticals

  • Olatec Industries

  • Otsuka Pharmaceutical

  • PLx Pharma

  • Orexo AB

  • Regeneron Pharmaceuticals Inc.

  • Recro Pharma, Inc

  • Relmada Therapeutics, Inc

  • Scintilla Pharmaceuticals, Inc.

  • Trevena Inc.

  • Trigemina, Inc.

  • WEX Phamaceuticals Inc

  • Zynerba Pharmaceuticals, Inc.


Research Methodologies


  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

United States Pain Management Therapeutics Market, Patients Volume, and 50 Company’s Pipeline Analysis (By Product, Indication, Phase of Development)

Table of Contents

1. Executive Summary

2. United States - Pain Management Therapeutics Market

3. United States - Pain Management Patient Population

4. United States - Pain Management Therapeutics Market Share

5. United States - Segment Wise Pain Management Therapeutics Market & Population
5.1 United States - Arthritis Pain Management Therapeutics Analysis (2007 - 2022)
5.1.1 United States - Arthritis Pain Management Therapeutics Market & Forecast
5.1.2 United States - Arthritis Pain Management Therapeutics Population & Forecast
5.2 United States - Migraine Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.2.1 United States - Migraine Pain Management Therapeutics Market & Forecast
5.2.2 United States - Migraine Pain Management Patient Population & Forecast
5.3 United States - Post Operative Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.3.1 United States - Post Operative Pain Management Therapeutics Market & Forecast
5.3.2 United States - Post Operative Pain Management Patient Population & Forecast
5.4 United States - Cancer Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.4.1 United States - Cancer Pain Management Therapeutics Market & Forecast
5.4.2 United States - Cancer Pain Management Patient Population & Forecast
5.5 United States - Neuropathic Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.5.1 United States - Neuropathic Pain Management Therapeutics Market & Forecast
5.5.2 United States - Neuropathic Pain Management Patient Population & Forecast
5.6 United States - Back Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.6.1 United States - Back Pain Management Therapeutics Market & Forecast
5.6.2 United States - Back Pain Management Patient Population & Forecast
5.7 United States - Fibromyalgia Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.7.1 United States - Fibromyalgia Pain Management Therapeutics Market & Forecast
5.7.2 United States - Fibromyalgia Pain Management Patient Population & Forecast
5.8 United States - Facial Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.8.1 United States - Facial Pain Management Therapeutics Market & Forecast
5.8.2 United States - Facial Pain Management Patient Population & Forecast
5.9 United States - Pediatric Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.9.1 United States - Pediatric Pain Management Therapeutics Market & Forecast
5.9.2 United States - Pediatric Pain Management Patient Population & Forecast
5.10 United States - Obstetrical Pain Management Therapeutics Market, Population & Forecast (2005 - 2018)
5.10.1 United States - Obstetrical Pain Management Therapeutics Market & Forecast

6. Pain Management Therapeutics Pipeline Products - By Company, Indication, Phase of Development

7. United States Pain Management Therapeutics Market - Driving Factors
7.1 Elderly Population
7.2 Unmet Need but Strong Pipeline Products

8. United States Pain Management Therapeutics Market - Challenges
8.1 Pain Medications, Particularly Opioids, are Associated with Several Side Effects
8.2 Difficulty in Pain Diagnosis Leads to Low Prescription Rates
8.3 Availability of Generics

List of Tables

Table 4-1: United States - Pain Management Therapeutics Market Share (Percent), 2007 - 2016
Table 4-2: United States - Forecast for Pain Management Therapeutics Market Share (Percent), 2017 - 2022
Table 6-1: Pain Management Therapeutics - List of pipeline Products (By Company, Indication, Phase of Development), July 2017

List of Figures

Figure 2-1: United States - Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 2-2: United States - Forecast for Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 3-1: United States - Pain Management Patient Population (Million), 2007 - 2016
Figure 3-2: United States - Forecast for Pain Management Patient Population (Million), 2017 - 2022
Figure 5-1: United States - Arthritis Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-2: United States - Forecast for Arthritis Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-3: United States - Arthritis Pain Management Patient Population (Million), 2007 - 2016
Figure 5-4: United States - Forecast for Arthritis Pain Management Patient Population (Million), 2017 - 2022
Figure 5-5: United States - Migraine Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-6: United States - Forecast for Migraine Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-7: United States - Migraine Pain Management Patient Population (Million), 2007 - 2016
Figure 5-8: United States - Forecast for Migraine Pain Management Patient Population (Million), 2017 - 2022
Figure 5-9: United States - Post Operative Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-10: United States - Forecast for Post Operative Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-11: United States - Post Operative Pain Management Patient Population (Million), 2007 - 2016
Figure 5-12: United States - Forecast for Post Operative Pain Management Patient Population (Million), 2017 - 2022
Figure 5-13: United States - Cancer Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-14: United States - Forecast for Cancer Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-15: United States - Cancer Pain Management Patient Population (Million), 2007 - 2016
Figure 5-16: United States - Forecast for Cancer Pain Management Patient Population (Million), 2017 - 2022
Figure 5-17: United States - Neuropathic Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-18: United States - Forecast for Neuropathic Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-19: United States - Neuropathic Pain Management Patient Population (Million), 2007 - 2016
Figure 5-20: United States - Forecast for Neuropathic Pain Management Patient Population (Million), 2017 - 2022
Figure 5-21: United States - Back Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-22: United States - Forecast for Back Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-23: United States - Back Pain Management Patient Population (Million), 2007 - 2016
Figure 5-24: United States - Forecast for Back Pain Management Patient Population (Million), 2017 - 2022
Figure 5-25: United States - Fibromyalgia Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-26: United States - Forecast for Fibromyalgia Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-27: United States - Fibromyalgia Pain Management Patient Population (Million), 2007 - 2016
Figure 5-28: United States - Forecast for Fibromyalgia Pain Management Patient Population (Million), 2017 - 2022
Figure 5-29: United States - Facial Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-30: United States - Forecast for Facial Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-31: United States - Facial Pain Management Patient Population (Million), 2007 - 2016
Figure 5-32: United States - Forecast for Facial Pain Management Patient Population (Million), 2017 - 2022
Figure 5-33: United States - Pediatric Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-34: United States - Forecast for Pediatric Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 5-35: United States - Pediatric Pain Management Patient Population (Number), 2007 - 2016
Figure 5-36: United States - Forecast for Pediatric Pain Management Patient Population (Number), 2017 - 2022
Figure 5-37: United States - Obstetrical Pain Management Therapeutics Market (Million US$), 2007 - 2016
Figure 5-38: United States - Forecast for Obstetrical Pain Management Therapeutics Market (Million US$), 2017 - 2022
Figure 7-1: United States - Elderly Population 60 Years and Above (Million), 2007 - 2016
Figure 7-2: United States - Forecast for Elderly Population 60 Years and Above (Million), 2017 - 2022
Figure 7-3: Pain Management Therapeutics - Number of Pipeline Candidate in Development Phase

  • United States Peptide Therapeutics Market Report 2017
    Published: 18-Aug-2017        Price: US 3800 Onwards        Pages: 98
    In this report, the United States Peptide Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • United States Hypertrophic Cardiomyopathy Therapeutics Market Report 2017
    Published: 17-Aug-2017        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Hypertrophic Cardiomyopathy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market ......
  • Raynauds Disease - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Raynauds Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Raynauds Disease - Pipeline Review, H2 2017, provides an overview of the Raynauds Disease (Cardiovascular) pipeline landscape. Raynauds disease is a common condition that affects the blood supply to certain parts of the body, usually the fingers and toes. Predisposing factors include age, gender, family history and smok......
  • Batten Disease - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 53
    Batten Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease - Pipeline Review, H2 2017, provides an overview of the Batten Disease (Central Nervous System) pipeline landscape. Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten disease usually......
  • Trigeminal Neuralgia - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 54
    Trigeminal Neuralgia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H2 2017, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Symptoms include spontaneous attacks of pain o......
  • Visceral Pain - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 55
    Visceral Pain - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Visceral Pain - Pipeline Review, H2 2017, provides an overview of the Visceral Pain (Central Nervous System) pipeline landscape. Visceral pain is a type of nociceptive pain that comes from the internal organs. Symptoms include aches, cramps and diffuse pain. Treatment includes analgesics such as narcotics or NSAIDs and pai......
  • Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 119
    Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve cells, called motor neurons, in the spinal cord. These critically important c......
  • Liver Cirrhosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 90
    Liver Cirrhosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H2 2017, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The scar tissue damages the normal structure of the liver wh......
  • Global Peptide Therapeutics Sales Market Report 2017
    Published: 14-Aug-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global Peptide Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Peptide Therapeutics for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs